The results suggested that inhibiting PHGDH pharmacologically could inhibit the proliferation of FLT3-ITD+ AML cells and induce apoptosis and potentially involves activation of the Bcl-2/Bax signaling pathway. The gene discussed is PHGDH; the disease is acute myeloid leukemia.